Ryan Watts
Founder chez DENALI THERAPEUTICS INC.
Fortune : 50 M $ au 31/03/2024
Profil
Le Dr Ryan J. Watts est président, directeur général et directeur de Denali Therapeutics, Inc. Il est membre du conseil d'administration de Denali Therapeutics, Inc. Le Dr Watts était auparavant employé comme directeur du département des neurosciences par Genentech, Inc. Il a obtenu son diplôme de premier cycle à l'université de l'Utah et un doctorat à l'université de Stanford.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DENALI THERAPEUTICS INC.
1,75% | 29/03/2024 | 2 440 671 ( 1,75% ) | 50 M $ | 31/03/2024 |
Postes actifs de Ryan Watts
| Sociétés | Poste | Début |
|---|---|---|
| DENALI THERAPEUTICS INC. | Founder | 14/10/2013 |
Peel Therapeutics, Inc.
 Peel Therapeutics, Inc. BiotechnologyHealth Technology Peel Therapeutics, Inc. engages as pre-clinical stage biotech that is strategically positioned at the intersection of nature and technology. The company is founded by Joshua Schiffman and Avi Schroeder in 2015 and is headquartered in Salt Lake City, UT. | Director/Board Member | 23/02/2023 |
Anciens postes connus de Ryan Watts
| Sociétés | Poste | Fin |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Founder | 01/02/2015 |
Formation de Ryan Watts
| Stanford University | Doctorate Degree |
| University of Utah | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DENALI THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Peel Therapeutics, Inc.
Peel Therapeutics, Inc. BiotechnologyHealth Technology Peel Therapeutics, Inc. engages as pre-clinical stage biotech that is strategically positioned at the intersection of nature and technology. The company is founded by Joshua Schiffman and Avi Schroeder in 2015 and is headquartered in Salt Lake City, UT. | Health Technology |
